Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications

J Zielonka, J Joseph, A Sikora, M Hardy… - Chemical …, 2017 - ACS Publications
Mitochondria are recognized as one of the most important targets for new drug design in
cancer, cardiovascular, and neurological diseases. Currently, the most effective way to …

Insight into nanoparticle cellular uptake and intracellular targeting

B Yameen, WI Choi, C Vilos, A Swami, J Shi… - Journal of controlled …, 2014 - Elsevier
Collaborative efforts from the fields of biology, materials science, and engineering are
leading to exciting progress in the development of nanomedicines. Since the targets of many …

Smart Design of Nanomaterials for Mitochondria‐Targeted Nanotherapeutics

SS Liew, X Qin, J Zhou, L Li, W Huang… - Angewandte Chemie …, 2021 - Wiley Online Library
Mitochondria are the powerhouse of cells. They are vital organelles that maintain cellular
function and metabolism. Dysfunction of mitochondria results in various diseases with a …

Nanoparticles and their applications in cell and molecular biology

EC Wang, AZ Wang - Integrative biology, 2014 - academic.oup.com
Nanoparticles can be engineered with distinctive composition, size, shape, and surface
chemistry to enable novel techniques in a wide range of biological applications. The unique …

Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment

MS Khan, BHJ Gowda, WH Almalki, T Singh… - Drug discovery today, 2024 - Elsevier
Highlights•Mitochondria are involved in various physiochemical and biochemical
processes.•Owing to their crucial role in cellular metabolism, mitochondria are favored …

Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics

S Marrache, S Dhar - … of the National Academy of Sciences, 2012 - National Acad Sciences
Mitochondrial dysfunctions cause numerous human disorders. A platform technology based
on biodegradable polymers for carrying bioactive molecules to the mitochondrial matrix …

Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate …

S Biswas, NS Dodwadkar, PP Deshpande… - Journal of Controlled …, 2012 - Elsevier
Previously, stearyl triphenylphosphonium (STPP)-modified liposomes (STPP-L) were
reported to target mitochondria. To overcome a non-specific cytotoxicity of STPP-L, we …

[HTML][HTML] Nanopreparations for mitochondria targeting drug delivery system: current strategies and future prospective

Z Wang, W Guo, X Kuang, S Hou, H Liu - asian journal of pharmaceutical …, 2017 - Elsevier
Mitochondria are a novel and promising therapeutic target for diagnosis, treatment and
prevention of a lot of human diseases such as cancer, metabolic diseases and …

The bioactivities of sclareol: A mini review

J Zhou, X Xie, H Tang, C Peng, F Peng - Frontiers in Pharmacology, 2022 - frontiersin.org
Sclareol, a diterpene alcohol isolated from the herbal and flavor plant clary sage (Salvia
sclarea L.), is far-famed as the predominant ingredient in the refined oil of Salvia sclarea (L.) …

Surface conjugation of triphenylphosphonium to target poly (amidoamine) dendrimers to mitochondria

S Biswas, NS Dodwadkar, A Piroyan, VP Torchilin - Biomaterials, 2012 - Elsevier
Dendrimers have emerged as promising carriers for the delivery of a wide variety of pay-
loads including therapeutic drugs, imaging agents and nucleic acid materials into biological …